As shown in Fig. 3A, LMNB1 expression higher than median was significantly associated with poor prognosis of OS for cancers of ACC (p < 0.0001), LGG (Brain Lower Grade Glioma) (p = 0.0005), PAAD (p = 0.0076), KIRP (p = 0.0021), LIHC (p = 0.0034), MESO (Mesothelioma) (p = 0.047), SARC (Sarcoma) (p = 0.01), while with favorable prognosis of OS for cancers of LUSC (p = 0.038), THYM (Thymoma) (p = 0.009) (Fig. 3A). This evidence concerns the gene LMNB1 and thymoma.